Font Size:
a
A
A
Keyword [CRCL]
Result: 1 - 4 | Page: 1 of 1
1.
Effective combination of syngeneic HCT with CRCL vaccination to treat BCR-ABL+ leukemia, and, CD4+CD25+FOXP3+ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease
2.
Generation of tumor-specific immunity using HER2/neu positive tumor derived chaperone-rich cell lysate (CRCL)
3.
Activation of immune system function against cancer by heat shock proteins
4.
Optimizing immunity against BCR-ABL positive leukemia
<<First
<Prev Next>
Last>>
Jump to
